Sign In

Sara Aljama López

Oncology Diagnostic Liason at AstraZeneca Spain, expanding the frontiers of Personalized Medicine.

Sara Aljama López is currently serving as a Diagnostic Liaison at AstraZeneca in Spain, where she focuses on expanding the frontiers of personalized medicine, particularly in the field of oncology. She has a background in the biotechnology industry and is recognized for her contributions to medical affairs.23

In addition to her professional role, Aljama López is actively engaged in educational outreach, sharing her experiences in pursuing a scientific career with students.1 She has also been involved in initiatives aimed at improving cancer diagnostics in Spain, collaborating with various organizations to enhance the accuracy of cancer diagnoses.4

Her educational background includes studies in pharmaceutical and healthcare talent development, and she is based in Madrid, where she has built a network of over 500 contacts on LinkedIn.2

Highlights

May 29 · linkedin

🔈🔈🔈 New ESMO recommendations for the use of NGS

Tumour agnostic alterations, breast cancer, fusion detection, incidental findings or HRD detection technologies are addressed in this 2024 report.

Apr 1 · linkedin

Genomic instability, and specifically chromosomal instability, beautifully reviewed in its role in cancer.

Related Questions

What specific projects has Sara Aljama López worked on at AstraZeneca?
How did Sara Aljama López get involved in the field of personalized medicine?
What are Sara Aljama López's main responsibilities as a Diagnostic Liason at AstraZeneca?
What impact has Sara Aljama López made in the oncology field?
How does Sara Aljama López contribute to AstraZeneca's efforts in cancer diagnosis?
Sara Aljama López
Sara Aljama López, photo 1
Sara Aljama López, photo 2
Add to my network

Location

Madrid, Community of Madrid, Spain